RGD Peptide
IQA
CNX-2006
STAT5-IN-2
Sintilimab
SLMP53-1
PCC0208017
BRD4/CK2-IN-1
ODM-207
HDAC-IN-40
NSC 694621
EZH2-IN-13
MPT0E028
PARP-2-IN-1
AS-85
HIF1-IN-3
GNE-375
PROTAC PARP1 degrader
CC-99677
BI-853520
HIV-IN-6
LNA-A(Bz)amidite
5-Me-dC(Ac)amidite
2'-O,4'-C-Methyleneguanosine
N1-Methylpseudouridine-5′-triphosphate trisodium
7-TFA-ap-7-Deaza-dA
Clindamycin-d3(hydrochloride)
CHMFL-PI3KD-317
AZD8154
Eugenol-d3
Policresulen
ATR inhibitor 1
Dodecyltrimethylammonium(bromide)
Isoniazid-d4
PR-39 TFA
Tat-beclin 1
CA77,1
Ungeremine
YM-341619
Povorcitinib
Disitamab vedotin
JAK-IN-14
JAK1-IN-8
Erlotinib-13C6
Fresolimumab
Myelin Basic Protein TFA
ζ-Stat
JNJ-26481585
Vorapaxar sulfate
TAK-020
QLT0267
5-HT2B antagonist-1
Auglurant
YB-0158
Lepidiline C
PEG diamine
Solanidine
α-Cortolone
N-Nitrosomethylisopropylamine
Isoflupredone
